Hydroxychloroquine News and Research

RSS
Remdesivir likely to be highly effective treatment for COVID-19

Remdesivir likely to be highly effective treatment for COVID-19

Favipiravir does not attenuate the progression of COVID-19

Favipiravir does not attenuate the progression of COVID-19

Researchers use AI platform to identify best combination of available therapies against COVID-19.

Researchers use AI platform to identify best combination of available therapies against COVID-19.

Using AI to find optimal combination of available therapies against SARS-CoV-2

Using AI to find optimal combination of available therapies against SARS-CoV-2

Hydroxychloroquine found ineffective as post-exposure SARS-CoV-2 prophylaxis

Hydroxychloroquine found ineffective as post-exposure SARS-CoV-2 prophylaxis

Researchers identify potential drug combination to treat uveal melanoma

Researchers identify potential drug combination to treat uveal melanoma

New insight into role of autophagy in controlling SARS-CoV-2 infection

New insight into role of autophagy in controlling SARS-CoV-2 infection

Pharmacophore model helps find key protease inhibitor responsible for COVID-19

Pharmacophore model helps find key protease inhibitor responsible for COVID-19

OHDSI awarded $10 million FDA contract to support Biologics Effectiveness and Safety program

OHDSI awarded $10 million FDA contract to support Biologics Effectiveness and Safety program

Research suggests plant flavonols could serve as effective antivirals for SARS-CoV-2

Research suggests plant flavonols could serve as effective antivirals for SARS-CoV-2

KU Leuven vaccine candidate works against yellow fever and SARS-CoV-2 infection

KU Leuven vaccine candidate works against yellow fever and SARS-CoV-2 infection

Potential SARS-CoV-2 antiviral: Ionophore X-206 found to inhibit viral replication in cell cultures

Potential SARS-CoV-2 antiviral: Ionophore X-206 found to inhibit viral replication in cell cultures

Chloroquine/hydroxychloroquine could treat COVID-19 infection

Chloroquine/hydroxychloroquine could treat COVID-19 infection

Nucleic acid-hydrolyzing scFv 3D8 exhibits potent antiviral effects on SARS-CoV-2

Nucleic acid-hydrolyzing scFv 3D8 exhibits potent antiviral effects on SARS-CoV-2

Rutgers leading a clinical trial assessing combination treatment for coronavirus

Rutgers leading a clinical trial assessing combination treatment for coronavirus

How pharma money colors Operation Warp Speed’s quest to defeat COVID

How pharma money colors Operation Warp Speed’s quest to defeat COVID

Steam inhalation therapy found to inactivate SARS-CoV-2 virions

Steam inhalation therapy found to inactivate SARS-CoV-2 virions

Resveratrol shows potential as SARS-CoV-2 antiviral, study finds

Resveratrol shows potential as SARS-CoV-2 antiviral, study finds

Mefloquine shows potential as anti-SARS-CoV-2 drug

Mefloquine shows potential as anti-SARS-CoV-2 drug

Largest clinical trial launched to treat mild-to-moderate COVID-19 patients in Africa

Largest clinical trial launched to treat mild-to-moderate COVID-19 patients in Africa